Vivoryon Therapeutics N.V.
Biotechnology · Healthcare
1 appearance
Latest appearance 2026-04-23
Analyst
Oddo
Equibles does not estimate personal net worth.
Samir Devani is recorded as Analyst at Oddo. Samir Devani has spoken on 1 earnings call across 1 company, most recently for Vivoryon Therapeutics N.V. on April 23, 2026. The companies whose calls Samir Devani spoke on are classified in the Healthcare sector.
“I just wanted to continue the comment, Frank, that you made about the SGLT2s. You presented some sort of subgroup analyses with the results today. And I was just wondering how many of the diabetes patients in VivaMind were on SGLT2s anyway?”
Oddo
Analyst
Transcript header (unverified)
Vivoryon Therapeutics N.V.
Biotechnology · Healthcare
Full Year Results 2025
Vivoryon Therapeutics N.V.